Additional file 1 of Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis

Additional file 1 Supplementary file 1. PRISMA check list. Supplementary file 2. Search strategy. Supplementary file 3. PRISMA flow chart. Supplementary Table S1. The product information (raw materials, labeled efficacy, indications) of CPMs. Supplementary Table S2. The baseline characteristics of the included RCTs and subjects. Supplementary Table S3. Results of the network meta-analysis for joint tenderness (upper-right quadrant) and the joint swelling (lower-left quadrant). Supplementary Table S4. Results of the network meta-analysis for morning stiffness (upper-right quadrant) and ESR (lower-left quadrant). Supplementary Table S5. Risk-of-bias judgements for the included RCTs (RoB 2)